Abstract
Acquiring drug sensitivity profiles is challenging in rare epilepsies. Anecdotal evidence suggests that anti-seizure medications that block sodium channels as their primary mechanism of action exacerbate seizures in HCN1 developmental and epileptic encephalopathies (DEE), while sodium valproate is effective for some patients. The Hcn1 M294L heterozygous knock-in (Hcn1M294L) mouse carries the homologue of the recurrent gain-of-function HCN1 M305L pathogenic variant and recapitulates the seizure and some behavioural phenotypes observed in patients. We used this mouse model to study drug efficacy ...
Seguir leyendo →OCT